Jamey Mock

CFO

Equibles does not estimate personal net worth.

Get an email with a short summary when Moderna, Inc. publishes a filing, an earnings call transcript or a press release.

Get MRNA alerts

About Jamey Mock

Jamey Mock is recorded as CFO at Moderna, Inc. (MRNA). Jamey Mock has spoken on 9 earnings calls across 1 company, most recently for Moderna, Inc. on May 1, 2025. Moderna, Inc. is classified in the Biotechnology industry within the Healthcare sector. Other leadership on record at Moderna, Inc. includes Stéphane Bancel (CEO and Board Member), Noubar Afeyan (Chairman and Board Member), David W. Meline (CFO) and 7 others.

Jamey Mock on recent calls

“Today, I'll cover our first quarter financial results, our full-year outlook, and an updated operating cost framework as we look ahead to 2026 and 2027. Let's start with our first quarter financial results shown on Slide 7.”

CFO, Moderna, Inc. Q1 FY2025 Earnings Call · May 1, 2025

“Today, I'll walk through our financial results for the fourth quarter and full year 2024, providing insights into the key drivers behind our performance. I'll also outline our 2025 financial framework as we continue to optimize our operations and position the company for long-term success.”

CFO, Moderna, Inc. Q4 FY2024 Earnings Call · February 14, 2025

“Today, I will provide an overview of our financial results for the third quarter and share our outlook for the remainder of 2024. Let’s start by reviewing our commercial performance, which you can follow on Slide 14.”

CFO, Moderna, Inc. Q3 FY2024 Earnings Call · November 7, 2024

“Today I will walk you through our financial performance for the second quarter and also update you on our financial outlook for the remainder of 2024. Let me start with our commercial performance on Slide 9.”

CFO, Moderna, Inc. Q2 FY2024 Earnings Call · August 1, 2024

“Today, I will review our financial performance for both the fourth quarter and the full year of 2023. I'll also provide our financial framework for 2024. Let me start with a review of our commercial performance this year.”

CFO, Moderna, Inc. Q4 FY2023 Earnings Call · January 8, 2024